Nonradiographic Axial Spondyloarthritis News

News

Bimekizumab Demonstrates Rapid and Sustained Efficacy in Treating NrxSpA, Regardless of Prior TNF Inhibitor Exposure

12/21/2023

Hannah Musick

A new monoclonal antibody, bimekizumab (BKZ), demonstrated promising results in improving efficacy outcomes for patients with axial spondyloarthritis (axSpA), even in those who have lost response to TNF inhibitors or are intolerant to them,...

A new monoclonal antibody,...

12/21/2023

First Report Managed Care

News

NrxSpA Classification Holds Little Relevance in Daily Practice

11/06/2023

Jolynn Tumolo

While the terms nonradiographic axial spondyloarthritis (NrxSpA) and radiographic axial spondyloarthritis (R-axSpA) may sometimes be helpful for stratifying patients with axial spondyloarthritis (axSpA) in clinical studies, the terms are less...

While the terms nonradiographic...

11/06/2023

First Report Managed Care

News

Updated AS and NrxSpA Treatment Recommendations Identify Common Diagnosis Issues, Solutions

10/06/2023

Hannah Musick

Updated evidence-based recommendations were released for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis, including the use of biologics and the role of imaging in patient management.

Updated evidence-based...

10/06/2023

First Report Managed Care

News

Baseline MRI and CRP on Treatment Efficacy in NrxSpA

09/27/2023

Danielle Sposato

Over the past decade, biologics have made remarkable advancements in treating axial spondyloarthritis (axSpA). Despite these advances, many patients fail to attain full remission or inactive disease, with only approximately 60% achieving...

Over the past decade, biologics...

09/27/2023

First Report Managed Care

News

Upadacitinib Benefits Quality of Life and Work Productivity in Adults With NrAxSpA

08/29/2023

Jolynn Tumolo

Explore how Upadacitinib led to rapid and clinically meaningful gains in health-related quality of life and work productivity compared with placebo in patients with nonradiographic axial spondyloarthritis.

Explore how Upadacitinib led to...

08/29/2023

First Report Managed Care

News

Unfamiliarity With NrAxSpa Can Delay Diagnosis for Years

07/27/2023

Jolynn Tumolo

“Education on cardinal features, epidemiology, burden, and benefits of timely NrAxSpa diagnosis is warranted for health care providers who commonly manage back pain,” researchers advised.

“Education on cardinal features,...

07/27/2023

First Report Managed Care

News

Minimal Radiographic Progression Over 2 Years With Secukinumab for NrAxSpa

06/19/2023

Jolynn Tumolo

This study demonstrated minimal radiographic progression and sustained reduction in sacroiliac joint inflammation with secukinumab administered over 2 years for patients with NrAxSpa.

This study demonstrated minimal...

06/19/2023

First Report Managed Care

News

One-Fourth of Patients With NrAxSpa Experience No Disease Flare After Stopping Etanercept

05/23/2023

Jolynn Tumolo

Researchers investigate how the current differential diagnosis between radiographic and non-radiographic axial spondyloarthritis affects the prediction of patient outcomes.

Researchers investigate how the...

05/23/2023

First Report Managed Care

News

Continued Golimumab Superior to Withdrawal in Patients With Inactive NrAxSpa

04/21/2023

Jolynn Tumolo

Continued golimumab treatment was superior to withdrawal in preventing disease flares and achieving clinical responses in adults with inactive nonradiographic axial spondyloarthritis.

Continued golimumab treatment...

04/21/2023

First Report Managed Care

News

Spinal Schwannoma Found in Man With Nonradiographic Axial Spondyloarthritis

03/09/2023

Jolynn Tumolo

A case study detailed the incidence of a rare tumor in a 25-year-old patient with a history of nonradiographic axial spondyloarthritis.

A case study detailed the...

03/09/2023

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

Feature

Eplerenone Reduces Risk of Death, Hospitalization in Patients with Mild Systolic Heart Failure

03/21/2011

Kristina Woodworth

A placebo-controlled study has found that eplerenone, a selective mineralocorticoid-receptor antagonist, reduced the risk of both cardiovascular-related death and heart failure hospitalizations in patients with chronic systolic heart failure...

A placebo-controlled study has...

03/21/2011

First Report Managed Care

Conference Coverage

SOHO 2024 Insights: Examining the Use and Cost of Interferon Therapy for MPNs

09/13/2024

Amber Denham ;

In this interview, a leading expert discusses myeloproliferative neoplasms, as presented at the SOHO annual conference. Explore the interview to gain key insights into interferon therapies and important considerations for payers regarding...

In this interview, a leading...

09/13/2024

First Report Managed Care

News

Exploring the Mechanisms of FDA-Approved siRNA Treatments in Disease Therapy

09/20/2024

Hannah Musick ;

Explore the groundbreaking advancements in RNA interference (RNAi) therapeutics, with a focus on the 6 US Food and Drug Administration (FDA)-approved small interfering RNA (siRNA) treatments and how they are revolutionizing disease treatment...

Explore the groundbreaking...

09/20/2024

First Report Managed Care

News

Transmission of C difficile Between People and Pets Appears Rare

09/26/2023

Jolynn Tumolo

“It is unclear why pets appear to only infrequently acquire C difficile from their owners,” researchers wrote. “It may be that the canine gut microbiota is better able to provide colonization resistance against C difficile, even when in an...

“It is unclear why pets appear...

09/26/2023

First Report Managed Care

Conference Insider

New Phase I Peanut Allergy Immunotherapy Trial Produces Promising Results

03/20/2019

According to science released at AAAAI, a new phase 1 peanut allergy immunotherapy trial results in no severe side effects, including anaphylaxis. The immunotherapy is designed to remove risks of acute reactions during treatment.

According to science released at...

03/20/2019

First Report Managed Care

Video Insights

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Learn about the impacts of the...

05/24/2024

First Report Managed Care

Videos

Navigating Payment Models in the CGT Landscape: Insights and Innovations

05/21/2024

Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson

An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.

An expert discusses the...

05/21/2024

First Report Managed Care

Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP

Videos

Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations

05/15/2024

Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP

Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.

Learn about developments in...

05/15/2024

First Report Managed Care

Conference Coverage

Using Lenalidomide and Rituximab, Tazemetostat, or Bispecific Antibodies to Treat Patients With Follicular Lymphoma

04/06/2024

Featuring Peter Martin, MD

During the 2024 Great Debates & Updates in Hematologic Malignancies meeting in New York, Peter Martin, MD, argued in favor of alternative treatment regimens over CAR T-cell therapy for treating follicular lymphoma.

During the 2024 Great Debates &...

04/06/2024

Oncology

Videos

Personalizing Weight Loss Management With GLP-1 Agonists

04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc

Featuring Tejaswi Kompala, MD, head o...

Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.

Nonradiographic Axial Spondyloarthritis News

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products